Skip to main content

letter

. 1985 Mar 16;290(6471):857. doi: 10.1136/bmj.290.6471.857-b

Treatment of septic arthritis due to Mycobacterium kansasii.

PMCID: PMC1418608 PMID: 3919820

857

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

GUY L. R., CHAPMAN J. S. Susceptibility in vitro of unclassified mycobacteria to commonly used antimicrobials. Am Rev Respir Dis. 1961 Nov;84:746–749. doi: 10.1164/arrd.1961.84.5P1.746. [DOI] [PubMed] [Google Scholar]
KLINENBERG J. R., GRIMLEY P. M., SEEGMILLER J. E. DESTRUCTIVE POLYARTHRITIS DUE TO A PHOTOCHROMOGENIC MYCOBACTERIUM. N Engl J Med. 1965 Jan 28;272:190–193. doi: 10.1056/NEJM196501282720405. [DOI] [PubMed] [Google Scholar]
Molavi A., Weinstein L. In-vitro activity of erythromycin against atypical mycobacteria. J Infect Dis. 1971 Feb;123(2):216–219. doi: 10.1093/infdis/123.2.216. [DOI] [PubMed] [Google Scholar]
Singh G., Singh M. Erythromycin for BCG cold abscess. Lancet. 1984 Oct 27;2(8409):979–979. doi: 10.1016/s0140-6736(84)91190-5. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES